-
UK launches scheme to encourage development of novel antibiotics
europeanpharmaceuticalreview
June 23, 2020
The NHS is offering two contracts to pay pharma companies at the start of their research into antibiotics, to promote the development of new antimicrobials.
-
Dexamethasone to be available on NHS as COVID-19 treatment
europeanpharmaceuticalreview
June 23, 2020
The UK government has approved dexamethasone to be available on the NHS, following clinical trials proving its efficacy at reducing the risk of death for COVID-19 patients.
-
UK launches world's first ‘subscription-style’ payment model for antibiotics
pharmatimes
June 22, 2020
A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies upfront for their work will start this week.
-
NHS signs 'landmark' deal with Microsoft
pharmatimes
June 17, 2020
NHSX, NHS Digital and Microsoft have signed a 'landmark' deal which will save the NHS 'hundreds of millions of pounds' and enable all eligible organisations in England to access Microsoft 365 digital tools.
-
NHS accelerates launch of new radiotherapy
pharmatimes
June 16, 2020
NHS England is accelerating the launch of a new type of radiotherapy that requires fewer doses than current approaches, thus cutting the number of hospital visits for potentially vulnerable cancer patients.
-
NHS waiting lists could hit 10m by year end
pharmatimes
June 11, 2020
NHS waiting lists could swell to 10 million by the end of the year, and possibly higher if there is a second wave of COVID-19 and a lack of treatment or a vaccine, the NHS Confederation warns.
-
NHS rolls out new online support for diabetes management
pharmatimes
June 11, 2020
NHS England has launched new online services to allow people with diabetes to better manage their condition remotely during the coronavirus pandemic.
-
Government launches coronavirus test and trace service
pharmatimes
June 01, 2020
The UK government has today launched its NHS Test and Trace service in a bid to identify, contain and control coronavirus to reduce its spread and save lives.
-
NICE issues final guidance on NHS use of Bayer's Vitrakvi
pharmatimes
May 28, 2020
The National Institute for Health and Care Excellence (NICE) has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety of cancers.
-
People with diabetes at higher risk of amid pandemic
pharmatimes
May 21, 2020
NHS England is calling on people with diabetes to access the help available to them after new research showed that those living with the condition are at significantly higher risk of dying with COVID-19.